search
Back to results

Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke (ZODIAC)

Primary Purpose

Ischemic Stroke

Status
Unknown status
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Head of Bed Positioning
Sponsored by
University of Tennessee
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ischemic Stroke

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Ischemic stroke symptoms consistent with large artery occlusion
  • Baseline standard of care non-contrast head CT (or MRI) negative for hemorrhage or mass-effect
  • Evidence of arterial occlusion on standard of care CT angiography or MR angiography
  • Favorable neuroimaging (Alberta Stroke Program Early Computed Tomography Score [ASPECTS] > 6 in anterior circulation stroke; not applicable in posterior circulation stroke)
  • Ordered treatment with mechanical thrombectomy
  • Pre-stroke baseline modified Rankin Score (mRS) < 1
  • Ability to enroll, randomize and begin the intervention within the Emergency Department

Exclusion Criteria:

  • Non-English speaking subjects will be excluded due to use of English language instruments (modified Rankin Scale [mRS] & NIHSS) and English speaking investigators
  • Pregnancy or suspicion of pregnancy
  • Evidence or suspicion of vomiting any time prior to consent which could predispose to aspiration pneumonia and therefore confound determination of protocol safety
  • Anticipated palliative care referral
  • Evidence of evolving malignant infarction on admission noncontrast CT (or MRI)
  • Need for intubation with mechanical ventilation, or non-invasive ventilatory support with either bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP)
  • Inability to tolerate zero-degree positioning due to congestive heart failure, preexisting pneumonia, chronic obstructive pulmonary disease, or other medical condition
  • Admission chest radiograph positive for pleural effusion, pulmonary edema, pneumonia, or other pulmonary condition that may confound determination of protocol safety
  • Abnormal breath sounds on admission assessment that may confound determination of protocol safety
  • Lack of a telephone and/or permanent address predisposing patients to be lost to follow up
  • Enrollment in another clinical trial that may affect our primary or secondary endpoints
  • In the absence of a consenting legal next of kin, any medical, psychological, cognitive, social or legal condition that would interfere with informed consent and/or capacity to comply with all study requirements, including the necessary time commitment

Sites / Locations

  • Mobile Infirmary Medical CenterRecruiting
  • Ronald Reagan UCLA Medical Center
  • Doctors Medical CenterRecruiting
  • Northwestern Central DuPage HospitalRecruiting
  • University of Louisville HospitalRecruiting
  • Moses Cone Medical Center
  • Saint Francis Health SystemRecruiting
  • Hershey Medical Center - Penn State HealthRecruiting
  • Methodist University HospitalRecruiting
  • Medical City - Fort WorthRecruiting
  • Memorial Hermann HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Zero Degree HOB

Thirty Degree HOB

Arm Description

Randomization to zero degree head of bed positioning until the time of initiation of thrombectomy

Randomization to thirty degree head of bed positioning until the time of initiation of thrombectomy

Outcomes

Primary Outcome Measures

Early Neurologic Deterioration (END) on the National Institute of Health Stroke Scale Occurring During the Positioning Intervention
Two or more point-worsening in the National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score during the positioning intervention period.

Secondary Outcome Measures

Severe Neurological Deterioration (SND) on the National Institute of Health Stroke Scale Occurring During the Positioning Intervention
Four or more point-worsening in the National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score during the positioning intervention period.
Diagnosis of Pneumonia Made During Hospitalization in a Patient Free From Pneumonia at Time of Hospital Admission
Documented onset of a new or progressive infiltrate on pulmonary imaging along with the presence of at least two of the following - Fever of 38°C/100.4°F; Purulent sputum; Leukocytosis or leukopenia; and/or, Decline in oxygen saturation.
Participant Deaths within 90-days from Stroke Onset
All cause death occurring from time of randomization up until 90-days from stroke onset
National Institutes of Health Stroke Scale Score at Hospital Discharge or Day 7
Total National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score measured at the time of hospital discharge or on day 7
Modified Rankin Scale Score at Hospital Discharge or Day 7
Categorical rank on the Modified Rankin Scale score (stroke functional outcome measure ranging from 0-no functional disability, to 6-dead) measured at the time of hospital discharge or on day 7 (whichever comes first)
Modified Rankin Scale Score at 90-days from Stroke Onset
Categorical rank on the Modified Rankin Scale score (stroke functional outcome measure ranging from 0-no functional disability, to 6-dead) measured at 90 days from stroke onset

Full Information

First Posted
October 23, 2018
Last Updated
March 28, 2020
Sponsor
University of Tennessee
Collaborators
National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT03728738
Brief Title
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
Acronym
ZODIAC
Official Title
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
September 25, 2018 (Actual)
Primary Completion Date
June 30, 2022 (Anticipated)
Study Completion Date
June 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Tennessee
Collaborators
National Institute of Nursing Research (NINR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Placing the head of bed (HOB) at 0-degrees has been shown in small studies to improve blood flow to the brain in patients with ischemic stroke caused by large artery occlusions, thereby reducing stroke symptom worsening. This simple yet potentially impactful intervention has yet to be tested in a large clinical trial in hyperacute large artery ischemic stroke patients, but may provide nurses with a powerful contribution to acute stroke care that is capable of preventing worsening of stroke symptoms and promoting stabilization. Because stroke is the leading cause of preventable long-term disability in adults, this study may show that simple methods such as 0-degree HOB positioning should be considered one of the very first actions taken in the emergent management of acute ischemic stroke patients.
Detailed Description
Positioning of the patient during hyperacute ischemic stroke (AIS) treatment is an important, yet understudied aspect of nursing care that could impact the course of treatment and clinical outcome. Since 1968, clinical symptom worsening in AIS patients has been documented with the head of bed (HOB) elevated to 30 degrees or higher, while clinical improvement or symptom stability has been noted with zero degree HOB positioning. Mechanisms for zero degree HOB clinical improvement include favorable gravitational blood flow conditions and recruitment of collateral blood channels, while in the case of treatment with clot-busting medications, increased blood flow may allow more medication to reach occluded arteries facilitating clot breakdown. Despite this, there is currently divide within the clinical community about what position is best for patients, although it has been argued that zero degree head positioning should be among the first steps taken to improve blood flow to the brain and prevent stroke symptom worsening. The investigators have shown that elevated ICP is absent in early AIS, and that pneumonia is rare using these piloted methods. However, no large clinical trial has examined efficacy and safety of zero degree HOB positioning within hyperacute large vessel occlusion (LVO) ischemic stroke patients with potentially viable brain tissue, leaving the acute stroke community confused as to what constitutes best practice. ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial of head positioning to determine if zero degree HOB positioning during the early phase of hyperacute LVO ischemic stroke management prevents neurological symptom worsening. Mechanical thrombectomy (MT) eligible patients (n=182) will be randomized to one of two groups: 1) Zero degree HOB positioning; or, 2) thirty degree HOB positioning. The hypothesis is that optimal HOB position can be determined by early neurological symptom worsening during the intervention (Aim 1) prior to initiation of the thrombectomy procedure, and the investigators propose that real-time deterioration may be a surrogate measure for decreased downstream perfusion, potentially impacting viability of brain at risk for infarction. Aim 2 will confirm that use of zero degree HOB positioning for AIS is safe. Use of this nursing measure holds significant promise as an innovative adjunct method to improve AIS symptoms, and ultimately reduce disability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Prospective randomized open blinded endpoint (PROBE) clinical trial using clinical assessors blinded to the intervention to determine neurologic deterioration on the NIH Stroke Scale Score following positioning to either zero degree or thirty degree heights.
Allocation
Randomized
Enrollment
182 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Zero Degree HOB
Arm Type
Experimental
Arm Description
Randomization to zero degree head of bed positioning until the time of initiation of thrombectomy
Arm Title
Thirty Degree HOB
Arm Type
Active Comparator
Arm Description
Randomization to thirty degree head of bed positioning until the time of initiation of thrombectomy
Intervention Type
Procedure
Intervention Name(s)
Head of Bed Positioning
Intervention Description
The head of bed (HOB) position will be selected through computerized randomization, and will include either zero degree positioning or thirty degree HOB elevation
Primary Outcome Measure Information:
Title
Early Neurologic Deterioration (END) on the National Institute of Health Stroke Scale Occurring During the Positioning Intervention
Description
Two or more point-worsening in the National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score during the positioning intervention period.
Time Frame
Measured every 10 minutes from initiation of positioning up until thrombectomy commences or 2 hours - whichever comes first
Secondary Outcome Measure Information:
Title
Severe Neurological Deterioration (SND) on the National Institute of Health Stroke Scale Occurring During the Positioning Intervention
Description
Four or more point-worsening in the National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score during the positioning intervention period.
Time Frame
Measured every 10 minutes from initiation of positioning up until thrombectomy commences or 2 hours - whichever comes first
Title
Diagnosis of Pneumonia Made During Hospitalization in a Patient Free From Pneumonia at Time of Hospital Admission
Description
Documented onset of a new or progressive infiltrate on pulmonary imaging along with the presence of at least two of the following - Fever of 38°C/100.4°F; Purulent sputum; Leukocytosis or leukopenia; and/or, Decline in oxygen saturation.
Time Frame
Measured up until hospital discharge or day 7 (whichever comes first)
Title
Participant Deaths within 90-days from Stroke Onset
Description
All cause death occurring from time of randomization up until 90-days from stroke onset
Time Frame
Up until 90-days from stroke onset
Title
National Institutes of Health Stroke Scale Score at Hospital Discharge or Day 7
Description
Total National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score measured at the time of hospital discharge or on day 7
Time Frame
Measured at hospital discharge or by day 7 (whichever comes first)
Title
Modified Rankin Scale Score at Hospital Discharge or Day 7
Description
Categorical rank on the Modified Rankin Scale score (stroke functional outcome measure ranging from 0-no functional disability, to 6-dead) measured at the time of hospital discharge or on day 7 (whichever comes first)
Time Frame
Measured at hospital discharge or on day 7 (whichever comes first)
Title
Modified Rankin Scale Score at 90-days from Stroke Onset
Description
Categorical rank on the Modified Rankin Scale score (stroke functional outcome measure ranging from 0-no functional disability, to 6-dead) measured at 90 days from stroke onset
Time Frame
Measured at 90 days from Stroke Onset

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ischemic stroke symptoms consistent with large artery occlusion Baseline standard of care non-contrast head CT (or MRI) negative for hemorrhage or mass-effect Evidence of arterial occlusion on standard of care CT angiography or MR angiography Favorable neuroimaging (Alberta Stroke Program Early Computed Tomography Score [ASPECTS] > 6 in anterior circulation stroke; not applicable in posterior circulation stroke) Ordered treatment with mechanical thrombectomy Pre-stroke baseline modified Rankin Score (mRS) < 1 Ability to enroll, randomize and begin the intervention within the Emergency Department Exclusion Criteria: Non-English speaking subjects will be excluded due to use of English language instruments (modified Rankin Scale [mRS] & NIHSS) and English speaking investigators Pregnancy or suspicion of pregnancy Evidence or suspicion of vomiting any time prior to consent which could predispose to aspiration pneumonia and therefore confound determination of protocol safety Anticipated palliative care referral Evidence of evolving malignant infarction on admission noncontrast CT (or MRI) Need for intubation with mechanical ventilation, or non-invasive ventilatory support with either bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) Inability to tolerate zero-degree positioning due to congestive heart failure, preexisting pneumonia, chronic obstructive pulmonary disease, or other medical condition Admission chest radiograph positive for pleural effusion, pulmonary edema, pneumonia, or other pulmonary condition that may confound determination of protocol safety Abnormal breath sounds on admission assessment that may confound determination of protocol safety Lack of a telephone and/or permanent address predisposing patients to be lost to follow up Enrollment in another clinical trial that may affect our primary or secondary endpoints In the absence of a consenting legal next of kin, any medical, psychological, cognitive, social or legal condition that would interfere with informed consent and/or capacity to comply with all study requirements, including the necessary time commitment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stephanie Breuer, MS
Phone
901-448-6424
Email
sbreuer@uthsc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne W Alexandrov, PhD
Organizational Affiliation
University of Tennessee Health Science Center at Memphis
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mobile Infirmary Medical Center
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36607
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jackie Owens, MSN
Email
Jackie.Owens@InfirmaryHealth.org
Facility Name
Ronald Reagan UCLA Medical Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Liebeskind, MD
Facility Name
Doctors Medical Center
City
Modesto
State/Province
California
ZIP/Postal Code
95350
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dharati Trivedi, MS
Email
Dharati.Trivedi@tenethealth.com
Facility Name
Northwestern Central DuPage Hospital
City
Winfield
State/Province
Illinois
ZIP/Postal Code
60190
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Abbigayle Doerr, DNP
Facility Name
University of Louisville Hospital
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Betsy Wise, MSN
Facility Name
Moses Cone Medical Center
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27401
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sharon Biby, MSN
Facility Name
Saint Francis Health System
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74136
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Matthew Holzmann, MSN
Email
MJHolzmann@saintfrancis.com
Facility Name
Hershey Medical Center - Penn State Health
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alicia Richardson, MSN
Email
arichardson2@pennstatehealth.psu.edu
Facility Name
Methodist University Hospital
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anne W Alexandrov, PhD
Facility Name
Medical City - Fort Worth
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cara Guthrie-Chu, MSN
Facility Name
Memorial Hermann Hospital
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicole Gonzales, MD
Email
Nicole.R.Gonzales@uth.tmc.edu

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke

We'll reach out to this number within 24 hrs